Diffusion MRI in prostate cancer with ultra-strong whole-body gradients

Malwina Molendowska1, Marco Palombo1,2, Kieran G Foley3

  • 1Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, UK.

NMR in Biomedicine
|August 27, 2024
PubMed

Insights

High-strength gradients in MRI significantly improve signal and contrast for prostate cancer detection. This advancement enhances diagnostic accuracy and image quality, paving the way for earlier cancer detection.

Area of Science:

  • Magnetic Resonance Imaging
  • Oncology
  • Medical Physics

Background:

  • Diffusion-weighted MRI (dMRI) is crucial for prostate cancer (PCa) detection and classification, adhering to PI-RADS guidelines.
  • Clinical dMRI faces limitations due to low signal-to-noise ratio (SNR) from prolonged echo times and restricted gradient power (40-80 mT/m).

Purpose of the Study:

  • To evaluate the feasibility, data quality, SNR, and contrast-to-noise ratio (CNR) of dMRI in PCa using a 300 mT/m whole-body MRI system.
  • To compare high-field gradient performance against clinical systems for prostate imaging.

Main Methods:

  • Utilized a 3T Connectom Siemens MRI system with 300 mT/m gradient amplitude on patients with and without PCa.
  • Acquired dMRI at high b-values with high gradients, comparing them to simulated clinical gradient capabilities.
  • Assessed image artifacts, their correction, SNR gains, lesion-to-healthy tissue CNR, and diagnostic quality using radiologist scoring.

Main Results:

  • High gradients significantly increased SNR per unit time and achieved a 1.6-2.1-fold increase in CNR compared to clinical gradients.
  • Despite increased artifacts with stronger gradients, satisfactory correction was achieved.
  • Shorter echo times resulted in smoother, less biased parameter maps.

Conclusions:

  • Whole-body 300 mT/m MRI is feasible for prostate dMRI without adverse physiological effects.
  • Stronger gradients enhance SNR and CNR in PCa dMRI, with artifacts being manageable.
  • This technology offers potential for improved early detection and diagnostic precision in prostate cancer.